CAXTON CORP's Net Worth

$1.46 Billion

Estimate Recalculated Feb 7, 2024 03:48PM EST

Who is CAXTON CORP?

CAXTON CORP has an estimated net worth of $1.46 Billion. This is based on reported shares across multiple companies, which include SYNTA PHARMACEUTICALS CORP, Strongbridge Biopharma plc, Kala Pharmaceuticals, Inc., Molecular Templates, Inc., and Celator Pharmaceuticals Inc.

SEC CIK

CAXTON CORP's CIK is 0001388551

Past Insider Trading and Trends

2018 was CAXTON CORP's most active year for acquiring shares with 16 total transactions. CAXTON CORP's most active month to acquire stocks was the month of June. 2017 was CAXTON CORP's most active year for disposing of shares, totalling 2 transactions. CAXTON CORP's most active month to dispose stocks was the month of June. 2019 saw CAXTON CORP paying a total of $3,750,000.00 for 468,750 shares, this is the most they've acquired in one year. In 2021 CAXTON CORP cashed out on 10,280,682 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

SYNTA PHARMACEUTICALS CORP (MDGL) Snapshot price: $188.73

Investor

CAXTON CORP owns 7,761,716 units of Common Stock which is worth $1,464,868,660.68. In the year 2007 CAXTON CORP filed a total of 2 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+27.85%
1.69M
7.76M
Feb 9
Form 3
0
0
No matching records found

Strongbridge Biopharma plc No price found

Investor

CAXTON CORP used to own units in Ordinary Shares, $0.01 par value but no longer holds any shares there. From 2018 to 2022 CAXTON CORP acquired a total of 2,662,648 shares in Strongbridge Biopharma plc at a cost of $8,828,116.41, CAXTON also disposed a total of 8,060,682 shares of Strongbridge Biopharma plc.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-8.06M
0
Oct 5
Form 4
+22.48%
1.48M
$2.25
$3,328,298.25
8.06M
Sep 17 - Sep 18
Form 4
+0.76%
49.4K
$3.99
$197,131.71
6.58M
Dec 26 - Dec 27
Form 4
+3.77%
237.08K
$3.98
$943,374.55
6.53M
Dec 20 - Dec 21
Form 4
+6.08%
361K
$4.93
$1,778,514.07
6.29M
Aug 8
Form 4
+1.19%
70K
$4.66
$326,466.00
5.93M
Jul 30
Form 4
+3.55%
399.1K
$4.83
$1,923,180.69
11.63M
Jul 24 - Jul 27
Form 4
+1.03%
55.5K
$4.96
$275,521.86
5.46M
Jul 19 - Jul 23
Form 4
+0.21%
11.2K
$4.97
$55,629.28
5.41M
Jul 16
Form 3
0
0
No matching records found

Kala Pharmaceuticals, Inc. (KALA) Snapshot price: $7.1

Investor

CAXTON CORP owns 763,755 units of Common Stock which is worth $5,422,660.50. In the year 2017 CAXTON CORP filed a total of 4 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
763.75K
$15.00
763.75K
Jul 20
Form 4/A
763.75K
$15.00
763.75K
Jul 20
Form 4
215K
$15.00
$3,225,000.00
215K
Jul 20
Form 3
0
0
No matching records found

Molecular Templates, Inc. (MTEM) Snapshot price: $3.59

Investor

CAXTON CORP owns 5,196,473 units of Common Stock which is worth $18,655,338.07. From 2017 to 2019 CAXTON CORP acquired a total of 1,039,204 shares in Molecular Templates, Inc. at a cost of $6,836,247.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+29.59%
468.75K
$8.00
$3,750,000.00
2.05M
Nov 21
Form 4
+1.60%
25K
$3.45
$86,250.00
1.58M
Dec 26
Form 4
+53.80%
545.45K
$5.50
$2,999,997.00
1.56M
Sep 25
Form 3
0
0
No matching records found

Celator Pharmaceuticals Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found